For instance, aberrant expression of enhancer of zeste homolog 2 (EZH2) in pancreatic cancer cells has been linked to gemcitabine resistance, possibly due to the downregulation of the tumor suppressor p27Kip1 [12]. This evidence concerns the gene EZH2 and pancreatic neoplasm.